Campbell Rogers's most recent trade in Heartflow Inc was a trade of 64,533 Common Stock done at an average price of $24.6 . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.64 per share. | 01 Apr 2026 | 64,533 | 81,002 | - | 24.6 | 1,590,093 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 40,766 | 81,633 | - | - | Stock Option | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 01 Apr 2026 | 40,766 | 138,686 | - | 2.2 | 90,501 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 19,111 | 122,399 | - | - | Stock Option | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 01 Apr 2026 | 19,111 | 97,920 | - | 2.2 | 42,426 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 6,849 | 0 | - | - | Stock Options | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 01 Apr 2026 | 6,849 | 145,535 | - | 2.2 | 15,205 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.33 per share. | 01 Apr 2026 | 291 | 78,809 | - | 8.3 | 2,424 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 291 | 3,298 | - | - | Stock Option | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.69 per share. | 19 Mar 2026 | 64,533 | 78,518 | - | 25.7 | 1,658,033 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2026 | 47,615 | 141,510 | - | - | Stock Option | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 19 Mar 2026 | 47,615 | 143,051 | - | 2.2 | 105,705 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 19 Mar 2026 | 19,402 | 95,436 | - | 2.2 | 43,072 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2026 | 19,402 | 189,125 | - | - | Stock Option | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.49 per share. | 12 Feb 2026 | 65,153 | 76,034 | - | 24.5 | 1,595,486 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 39,709 | 0 | - | - | Stock Option | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.33 per share. | 12 Feb 2026 | 39,709 | 133,281 | - | 8.3 | 330,776 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 19,401 | 216,433 | - | - | Stock Option | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 12 Feb 2026 | 19,401 | 93,572 | - | 2.2 | 43,070 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 7,906 | 208,527 | - | - | Stock Option | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 12 Feb 2026 | 7,906 | 141,187 | - | 2.2 | 17,551 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 94,488 | 94,488 | - | - | Stock Option | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 54,073 | 74,171 | - | 0 | Common Stock | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.74 per share. | 06 Feb 2026 | 515 | 20,098 | - | 27.7 | 14,286 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.56 per share. | 07 Nov 2025 | 439 | 20,613 | - | 32.6 | 14,294 | Common Stock |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 110,629 | 110,629 | - | - | Stock Options | |
| Heartflow Inc | Campbell D.K. Rogers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 21,052 | 21,052 | - | 0 | Common Stock | |
| InspireMD Inc | Campbell D. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 17,248 | 27,960 (0%) | 0% | 0 | Common Stock | |
| InspireMD Inc | Campbell D. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 5,749 | 5,749 | - | - | Options to purchase common stock (right to buy) |